Neurogranin and BACE1 in CSF as Potential Biomarkers Differentiating Depression with Cognitive Deficits from Early Alzheimer's Disease: A Pilot Study

por Schipke, Carola G., De Vos, Ann, Fuentes, Manuel, Jacobs, Dirk, Vanmechelen, Eugeen, Peters, Oliver
Publicado 2018

Plasma Amyloid Concentration in Alzheimer’s Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer’s Disease Cases from Controls

por Feinkohl, Insa, Schipke, Carola G., Kruppa, Jochen, Menne, Felix, Winterer, Georg, Pischon, Tobias, Peters, Oliver
Publicado 2020

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease

por Bader, Jakob M, Geyer, Philipp E, Müller, Johannes B, Strauss, Maximilian T, Koch, Manja, Leypoldt, Frank, Koertvelyessy, Peter, Bittner, Daniel, Schipke, Carola G, Incesoy, Enise I, Peters, Oliver, Deigendesch, Nikolaus, Simons, Mikael, Jensen, Majken K, Zetterberg, Henrik, Mann, Matthias
Publicado 2020

Tau plasma levels in subjective cognitive decline: Results from the DELCODE study

por Müller, Stephan, Preische, Oliver, Göpfert, Jens C., Yañez, Viviana A. Carcamo, Joos, Thomas O., Boecker, Henning, Düzel, Emrah, Falkai, Peter, Priller, Josef, Buerger, Katharina, Catak, Cihan, Janowitz, Daniel, Heneka, Michael T., Brosseron, Frederic, Nestor, Peter, Peters, Oliver, Menne, Felix, Schipke, Carola G., Schneider, Anja, Spottke, Annika, Fließbach, Klaus, Kilimann, Ingo, Teipel, Stefan, Wagner, Michael, Wiltfang, Jens, Jessen, Frank, Laske, Christoph
Publicado 2017